The Current Ratio as of October 2024 (TTM) for Novan, Inc. (NOVN) is 0.74

According to Novan, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.74. This represents a change of -26.15% compared to the average of 1.01 of the last 4 quarters.

Novan, Inc. (NOVN) Historical Current Ratio (quarterly & annually)

How has NOVN Current Ratio performed in the past?

The mean historical Current Ratio of Novan, Inc. over the last ten years is 3.11. The current 0.74 Current Ratio has changed 2.29% with respect to the historical average. Over the past ten years (40 quarters), NOVN's Current Ratio was at its highest in in the December 2015 quarter at 9.21. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Novan, Inc. (NOVN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Novan, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novan, Inc. (NOVN) Average Current Ratio

How has NOVN Current Ratio performed in the past?

The current Current Ratio of Novan, Inc. (NOVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Novan, Inc. (NOVN) Current Ratio vs. Peers

How is NOVN’s Current Ratio compared to its peers?

Novan, Inc.’s Current Ratio is less than Tarsus Pharmaceuticals, Inc. (7.03), less than LianBio (10.06), less than Aldeyra Therapeutics, Inc. (4.41), less than Travere Therapeutics, Inc. (3.04), less than Eton Pharmaceuticals, Inc. (1.40), less than Tonix Pharmaceuticals Holding Corp. (1.15), less than Jaguar Health, Inc. (2.10), less than Acasti Pharma Inc. (7.86), less than Diffusion Pharmaceuticals Inc. (10.96), less than iBio, Inc. (4.08), greater than Aditxt, Inc. (0.07), less than Palisade Bio, Inc. (4.31), greater than Plus Therapeutics, Inc. (0.50), less than Revelation Biosciences, Inc. (1.10), less than Quoin Pharmaceuticals, Ltd. (3.35), less than Onconova Therapeutics, Inc. (1.93), less than Adial Pharmaceuticals, Inc. (5.69), less than Aeterna Zentaris Inc. (5.94), less than Lyra Therapeutics, Inc. (3.60), less than Trevi Therapeutics, Inc. (10.68), less than SQZ Biotechnologies Company (1.37), less than Protara Therapeutics, Inc. (16.33), greater than TRACON Pharmaceuticals, Inc. (0.66),

Build a custom stock screener for Novan, Inc. (NOVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novan, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novan, Inc. (NOVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novan, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.